{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:56:58Z","timestamp":1792457818168,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100032078","name":"College of Physicians and Surgeons of Alberta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032078","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010090","name":"Women and Children's Health Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jtha.2026.01.030","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T17:00:14Z","timestamp":1772643614000},"page":"1979-1992","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Rate of abnormal uterine bleeding in women on anticoagulation for venous thromboembolism: systematic review and meta-analysis"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0724-7554","authenticated-orcid":false,"given":"Nazanin Abolghasemi","family":"Taree","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Sivak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wei (Linda) Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.01.030_bib1","doi-asserted-by":"crossref","first-page":"879.e19","DOI":"10.1016\/j.amjmed.2016.01.041","article-title":"Secular trends in incidence and mortality of acute venous thromboembolism: the AB-VTE population-based study","volume":"129","author":"Alotaibi","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.jtha.2026.01.030_bib2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/hematology.2022000401","article-title":"Anticoagulant therapy for women: implications for menstruation, pregnancy, and lactation","volume":"2022","author":"DeLoughery","year":"2022","journal-title":"Hematology"},{"key":"10.1016\/j.jtha.2026.01.030_bib3","doi-asserted-by":"crossref","DOI":"10.1177\/20420986211062965","article-title":"Do women with venous thromboembolism bleed more than men during anticoagulation? Data from the real-life, prospective START-Register","volume":"12","author":"Palareti","year":"2021","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.jtha.2026.01.030_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijgo.2010.11.011","article-title":"FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age","volume":"113","author":"Munro","year":"2011","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.jtha.2026.01.030_bib5","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1182\/hematology.2020000138","article-title":"Management of heavy menstrual bleeding on anticoagulation","volume":"2020","author":"Samuelson Bannow","year":"2020","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtha.2026.01.030_bib6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.contraception.2010.12.011","article-title":"Menstrual problems and contraception in women of reproductive age receiving oral anti coagulation","volume":"84","author":"Huq","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.jtha.2026.01.030_bib7","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.01.030_bib8","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.7326\/M21-1094","article-title":"Long-term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism: a systematic review and meta-analysis","volume":"174","author":"Khan","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2026.01.030_bib9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1055\/a-1891-8187","article-title":"Bleeding issues in women under oral anticoagulation","volume":"42","author":"Kalmanti","year":"2022","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.jtha.2026.01.030_bib10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.maturitas.2015.08.014","article-title":"Practice points in gyne cardiology: abnormal uterine bleeding in premenopausal women taking oral anticoagulant or antiplatelet therapy","volume":"82","author":"Maas","year":"2015","journal-title":"Maturitas"},{"key":"10.1016\/j.jtha.2026.01.030_bib11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.thromres.2020.11.014","article-title":"Heavy menstrual bleeding in women on oral anticoagulants","volume":"197","author":"Samuelson Bannow","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.01.030_bib12","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.030_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2017.05.001","article-title":"Abnormal uterine bleeding in women receiving direct oral anticoagulants for the treatment of venous thromboembolism","volume":"93\u201395","author":"Godin","year":"2017","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.jtha.2026.01.030_bib14","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1182\/hematology.2020000166","article-title":"Abnormal uterine bleeding in users of rivaroxaban and apixaban","volume":"2020","author":"Jacobson-Kelly","year":"2020","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtha.2026.01.030_bib15","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2026.01.030_bib16","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2026.01.030_bib17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000320336","article-title":"Pictorial blood loss assessment chart in the evaluation of heavy menstrual bleeding: diagnostic accuracy compared to alkaline hematin","volume":"71","author":"Zakherah","year":"2011","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.jtha.2026.01.030_bib18","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ijgo.12666","article-title":"The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions","volume":"143","author":"Munro","year":"2018","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.jtha.2026.01.030_bib19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.thromres.2017.05.026","article-title":"Diagnosis of recurrent venous thromboembolism","volume":"163","author":"Barco","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.01.030_bib20","series-title":"The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","first-page":"1","author":"Peterson","year":"2011"},{"key":"10.1016\/j.jtha.2026.01.030_bib21","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2026.01.030_bib22","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMoa1700518","article-title":"Rivaroxaban or aspirin for extended treatment of venous thromboembolism","volume":"376","author":"Weitz","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.01.030_bib23","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.01.030_bib24","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa1915103","article-title":"Apixaban for the treatment of venous thromboembolism associated with cancer","volume":"382","author":"Agnelli","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.01.030_bib25","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Bauersachs","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.01.030_bib26","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1200\/JCO.2018.78.8034","article-title":"Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D)","volume":"36","author":"Young","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtha.2026.01.030_bib27","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/1471-0528.15388","article-title":"Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai-VTE study","volume":"125","author":"Scheres","year":"2018","journal-title":"BJOG"},{"key":"10.1016\/j.jtha.2026.01.030_bib28","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/bjh.14003","article-title":"Heavy menstrual bleeding on rivaroxaban - comparison with apixaban","volume":"176","author":"Myers","year":"2017","journal-title":"Br J Haemat"},{"key":"10.1016\/j.jtha.2026.01.030_bib29","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/rth2.12474","article-title":"Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: comparison of high-and low-dose rivaroxaban with aspirin","volume":"5","author":"Boonyawat","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.030_bib30","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1160\/TH16-11-0874","article-title":"Abnormal vaginal bleeding in women with venous thromboembolism treated with apixaban or warfarin","volume":"117","author":"Brekelmans","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.030_bib31","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2015-08-665927","article-title":"Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use","volume":"127","author":"Martinelli","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.030_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.thromres.2021.05.012","article-title":"Incidence of abnormal uterine bleeding in a multicenter implementation study using apixaban and rivaroxaban to treat venous thromboembolism","volume":"204","author":"Pagenhardt","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.01.030_bib33","doi-asserted-by":"crossref","first-page":"e354","DOI":"10.1055\/s-0042-1757744","article-title":"On-treatment comparative effectiveness of vitamin K antagonists and direct oral anticoagulants in GARFIELD-VTE, and focus on cancer and renal disease","volume":"6","author":"Haas","year":"2022","journal-title":"TH Open"},{"key":"10.1016\/j.jtha.2026.01.030_bib34","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s11239-021-02595-0","article-title":"Efficacy and safety of rivaroxaban in cerebral venous thrombosis: insights from a prospective cohort study","volume":"53","author":"Pan","year":"2022","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2026.01.030_bib35","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/rth2.12489","article-title":"Anticoagulant treatment for venous thromboembolism: a pooled analysis and additional results of the XALIA and XALIA-LEA noninterventional studies","volume":"5","author":"Haas","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.030_bib36","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0049-3848(17)30058-0","article-title":"Uterine bleeding during anticoagulation in women with venous thromboembolism","volume":"151","author":"Moustafa","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.01.030_bib37","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.vph.2016.11.003","article-title":"Heavy menstrual bleeding in women treated with rivaroxaban and vitamin K antagonists and the risk of recurrent venous thromboembolism","volume":"87","author":"Bryk","year":"2016","journal-title":"Vasc Pharmacol"},{"key":"10.1016\/j.jtha.2026.01.030_bib38","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1182\/blood.2022017101","article-title":"Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism","volume":"140","author":"De Jong","year":"2022","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtha.2026.01.030_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100072","article-title":"How do anticoagulants impact menstrual bleeding and quality of life? - the PERIOD study","volume":"7","author":"Patel","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.030_bib40","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/jth.14226","article-title":"Less abnormal uterine bleeding with dabigatran than warfarin in women treated for acute venous thromboembolism","volume":"16","author":"Huisman","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.030_bib41","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1160\/TH15-11-0902","article-title":"Vaginal bleeding and heavy menstrual bleeding during direct oral anti-Xa inhibitor therapy","volume":"115","author":"Beyer-Westendorf","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.030_bib42","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12905-020-0887-y","article-title":"Pictorial methods to assess heavy menstrual bleeding in research and clinical practice: a systematic literature review","volume":"20","author":"Magnay","year":"2020","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.jtha.2026.01.030_bib43","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1097\/AOG.0000000000003411","article-title":"Screening and management of bleeding disorders in adolescents with heavy menstrual bleeding: Acog Committee Opinion, Number 785","volume":"134","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jtha.2026.01.030_bib44","first-page":"657","article-title":"Incidence of venous thromboembolism: a community-based study in western France. EPI-GETBP study group. Groupe d\u2019Etude de la Thrombose de Bretagne Occidentale","volume":"83","author":"Oger","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.030_bib45","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/CIRCOUTCOMES.115.002369","article-title":"Dabigatran versus warfarin for atrial fibrillation in real-world clinical practice: a systematic review and meta-analysis","volume":"9","author":"Romanelli","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jtha.2026.01.030_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h1585","article-title":"Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study","volume":"350","author":"Chang","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2026.01.030_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102448","article-title":"Heavy menstrual bleeding on direct factor Xa inhibitors: the MEDEA randomized clinical trial","volume":"8","author":"Hamuly\u00e1k","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.030_bib48","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2026.01.030_bib49","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","article-title":"Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF)","volume":"151","author":"Gage","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jtha.2026.01.030_bib50","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1160\/TH08-03-0193","article-title":"Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry","volume":"100","author":"Ru\u00edz-Gim\u00e9nez","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.030_bib51","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1378\/chest.09-3081","article-title":"Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators","volume":"139","author":"Decousus","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2026.01.030_bib52","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2026.01.030_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1049283","article-title":"Comparative differences in the risk of major gastrointestinal bleeding among different direct oral anticoagulants: an updated traditional and Bayesian network meta-analysis","volume":"13","author":"Chen","year":"2023","journal-title":"Front Pharmacol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626001261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626001261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:05:53Z","timestamp":1780574753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626001261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1538783626001261"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.01.030","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rate of abnormal uterine bleeding in women on anticoagulation for venous thromboembolism: systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}